Bella Kaufman
Impact in
- Oncology top 0.1%
- HER2/EGFR in Cancer Research
- PARP inhibition in cancer therapy
- Cancer Treatment and Pharmacology
- Cancer Research top 0.5%
- Cancer Genomics and Diagnostics
- Breast Cancer Treatment Studies
Papers in
- Co-authors
- Mario Campone (12 shared papers)Raphael Catane (24 shared papers)Eric C. Rackow (13 shared papers)Jay L. Falk (9 shared papers)Ido Wolf (16 shared papers)Arlene Chan (2 shared papers)Stephen D. Rubin (2 shared papers)Tadeusz Pieńkowski (5 shared papers)
- Journals
- Journal of Clinical Oncology (36 papers)Annals of Oncology (22 papers)Cancer Research (16 papers)Breast Cancer Research and Treatment (11 papers)Critical Care Medicine (11 papers)
- Partner nations
- IsraelUnited StatesUnited Kingdom
In The Last Decade
Bella Kaufman
241 papers receiving 14.9k citations
Bella Kaufman's Hit Papers
Peers
Comparison fields: 5 of 159
- Oncology 6.8k
- Cancer Research 2.5k
- Critical Care and Intensive Care Medicine 518
- Reproductive Medicine 938
- Pulmonary and Respiratory Medicine 2.9k
Countries citing papers authored by Bella Kaufman
This map shows the geographic impact of Bella Kaufman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bella Kaufman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bella Kaufman more than expected).
Fields of papers citing papers by Bella Kaufman
This network shows the impact of papers produced by Bella Kaufman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bella Kaufman. The network helps show where Bella Kaufman may publish in the future.
Co-authors
The 25 scholars most cited alongside Bella Kaufman, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 252 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Lapatinib plus Capecitabine for HER2-Positive Advanced Breast Cancer Hit paper breakdown → | 2006 | 2514 |
| 2 | Alpelisib for PIK3CA -Mutated, Hormone Receptor–Positive Advanced Breast Cancer Hit paper breakdown → | 2019 | 1644 |
| 3 | Olaparib Monotherapy in Patients With Advanced Cancer and a Germline BRCA1/2 Mutation Hit paper breakdown → | 2014 | 1248 |
| 4 | Trastuzumab Plus Anastrozole Versus Anastrozole Alone for the Treatment of Postmenopausal Women With Human Epidermal Growth Factor Receptor 2–Positive, Hormone Receptor–Positive Metastatic Breast Cancer: Results From the Randomized Phase III TAnDEM Study Hit paper breakdown → | 2009 | 598 |
| 5 | Alpelisib plus fulvestrant for PIK3CA-mutated, hormone receptor-positive, human epidermal growth factor receptor-2–negative advanced breast cancer: final overall survival results from SOLAR-1 Hit paper breakdown → | 2020 | 391 |
| 6 | 2011 | 380 | |
| 7 | 2005 | 328 | |
| 8 | 2013 | 300 | |
| 9 | Fluid resuscitation in circulatory shock: a comparison of the cardiorespiratory effects of albumin, hetastarch, and saline solutions in patients with hypovolemic and septic shock. | 1983 | 282 |
| 10 | 2008 | 255 | |
| 11 | 2007 | 249 | |
| 12 | Founder BRCA1 and BRCA2 mutations in Ashkenazi Jews in Israel: frequency and differential penetrance in ovarian cancer and in breast-ovarian cancer families. | 1997 | 246 |
| 13 | 1983 | 246 | |
| 14 | 2014 | 237 | |
| 15 | 2015 | 220 | |
| 16 | 2006 | 153 | |
| 17 | 2007 | 153 | |
| 18 | 2001 | 152 | |
| 19 | 2008 | 152 | |
| 20 | 1984 | 146 |
About Bella Kaufman
Bella Kaufman is a scholar working on Oncology, Genetics, Pulmonary and Respiratory Medicine, Molecular Biology and Surgery, having authored 252 papers that have together received 15.4k indexed citations. Recurring topics across this work include BRCA gene mutations in cancer (49 papers), Cancer Treatment and Pharmacology (36 papers), Advanced Breast Cancer Therapies (35 papers), PARP inhibition in cancer therapy (35 papers), HER2/EGFR in Cancer Research (24 papers), Breast Cancer Treatment Studies (19 papers), Ovarian cancer diagnosis and treatment (15 papers) and DNA Repair Mechanisms (13 papers). The work is most often cited by research in Oncology (6.8k citations), Cancer Research (2.5k citations), Critical Care and Intensive Care Medicine (518 citations), Reproductive Medicine (938 citations) and Pulmonary and Respiratory Medicine (2.9k citations). Bella Kaufman has collaborated with scholars based in Israel, United States and United Kingdom. Frequent co-authors include Mario Campone, Raphael Catane, Eric C. Rackow, Jay L. Falk, Ido Wolf, Arlene Chan, Stephen D. Rubin, Tadeusz Pieńkowski, Cristina Oliva and Charles E. Geyer. Their work appears in journals such as Journal of Clinical Oncology, Annals of Oncology, Cancer Research, Breast Cancer Research and Treatment and Critical Care Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.